Citation: K. Rubsamen et M. Kirchengast, THROMBIN INHIBITION AND INTRACORONARY THROMBUS FORMATION - EFFECT OF POLYETHYLENE GLYCOL-COUPLED HIRUDIN IN THE STENOSED, LOCALLY INJURED CANINE CORONARY-ARTERY, Coronary artery disease, 9(1), 1998, pp. 35-42
Authors:
KIRCHENGAST M
HERGENRODER S
SCHULT S
MUNTER K
RUBSAMEN K
Citation: M. Kirchengast et al., ENDOTHELIN-1 AND UNSTABLE ANGINA - EFFECT OF EITHER ENDOTHELIN-ETA ORETB RECEPTOR ANTAGONISM IN A LOCALLY INJURED CANINE CORONARY-ARTERY, European journal of pharmacology, 341(2-3), 1998, pp. 187-190
Authors:
BODE C
KOHLER B
STEG G
PAROW C
RUBSAMEN K
Citation: C. Bode et al., THE ECARIN CLOTTING TIME BUT NOT THE APTT IS A RELIABLE INDICATOR FORPEG-HIRUDIN BLOOD-LEVELS IN PATIENTS WITH UNSTABLE ANGINA-PECTORIS, Journal of the American College of Cardiology, 29(2), 1997, pp. 3343-3343
Authors:
BADIMON JJ
ALZUETA AF
RATAN A
RUBSAMEN K
BADIMON L
FUSTER V
CHESEBRO JH
Citation: Jj. Badimon et al., THRESHOLD INHIBITION OF THROMBUS FORMATION BY PEG-HIRUDIN, A LONGER ACTING THROMBIN INHIBITOR, Thrombosis and haemostasis, 1997, pp. 364-364
Authors:
KYRLE PA
CHESEBRO JH
FUSTER V
RUBSAMEN K
BADIMON JJ
Citation: Pa. Kyrle et al., ANTITHROMBOTIC EFFECTS OF PEG-HIRUDIN, A NEW AND LONG-LASTING THROMBIN INHIBITOR, IN HUMANS, Thrombosis and haemostasis, 1997, pp. 2006-2006
Authors:
OBERHOFF M
HERDEG C
BAUMBACH A
SHAMET K
KRANZHOFER A
WEINGARTNER O
RUBSAMEN K
KLUGE M
KARSCH KR
Citation: M. Oberhoff et al., TIME-COURSE OF SMOOTH-MUSCLE CELL-PROLIFERATION AFTER LOCAL-DRUG DELIVERY OF LOW-MOLECULAR-WEIGHT HEPARIN USING A POROUS BALLOON CATHETER, Catheterization and cardiovascular diagnosis, 41(3), 1997, pp. 268-274
Authors:
HAAS S
ESSLINGER HU
RUBSAMEN K
JESKE WP
WALENGA JM
Citation: S. Haas et al., SUPERIOR PERFORMANCE OF ECARIN CLOTTING TIME OVER APTT FOR THE MONITORING OF PEG-HIRUDIN ACTIVITY IN PLASMA, Blood, 90(10), 1997, pp. 3225-3225
Citation: K. Rubsamen et W. Hornberger, PREVENTION OF EARLY REOCCLUSION AFTER THROMBOLYSIS OF COPPER COIL-INDUCED THROMBI IN THE CANINE CAROTID-ARTERY - COMPARISON OF PEG-HIRUDIN AND UNFRACTIONATED HEPARIN, Thrombosis and haemostasis, 76(1), 1996, pp. 105-110
Authors:
BAUMBACH A
OBERHOFF M
RUBSAMEN K
JOCHIMS K
HERDEG C
KRANZHOFER A
SAFER A
KARSCH KR
Citation: A. Baumbach et al., POROUS BALLOON DELIVERY OF LOW-MOLECULAR-WEIGHT HEPARIN IN THE DOG CORONARY-ARTERY, European heart journal, 17(10), 1996, pp. 1538-1545
Citation: K. Rubsamen et al., INHIBITION OF ARTERIAL THROMBUS FORMATION IN 2 CANINE MODELS - COMPARISON OF ANCROD, A FIBRINOGEN-DEPLETING AGENT, THE THROMBIN-INHIBITOR R-HIRUDIN, AND THE GLYCOPROTEIN IIB IIIA-RECEPTOR ANTAGONIST RO-43-8857/, Thrombosis and haemostasis, 74(5), 1995, pp. 1353-1360
Citation: V. Laux et al., EFFECT OF LOW-MOLECULAR-WEIGHT HEPARINS AND STANDARD HEPARIN ON HEMOSTATIC PLUG FORMATION IN RATS AFTER SUBCUTANEOUS ADMINISTRATION, Thrombosis and haemostasis, 73(6), 1995, pp. 966-966
Citation: V. Laux et al., LOWERING OF FIBRINOGEN LEVEL WITH THE DEFIBRINOGENATING AGENT ARVIN(R) INHIBITS THROMBUS DEVELOPMENT WITHOUT IMPAIRMENT OF HEMOSTASIS, Thrombosis and haemostasis, 73(6), 1995, pp. 1231-1231
Authors:
HORNBERGER W
RUBSAMEN K
LAUX V
SCHWEDEN J
Citation: W. Hornberger et al., NEW PROPERTIES OF AN OLD ANTITHROMBOTIC - LONG-ACTING HYDROPHOBIC HIRUDIN DERIVATIVES WITH HIGH-AFFINITY TO PLATELETS AND ARTIFICIAL SURFACES, Thrombosis and haemostasis, 73(6), 1995, pp. 1451-1451
Authors:
CALLAS DD
HOPPENSTEADT D
IOBAL O
RUBSAMEN K
FAREED J
Citation: Dd. Callas et al., ECARIN CLOTTING TIME (ECT) IS A RELIABLE METHOD FOR THE MONITORING OFHIRUDINS, ARGATROBAN, EFEGATRAN AND RELATED DRUGS IN THERAPEUTIC AND CARDIOVASCULAR INDICATIONS, Blood, 86(10), 1995, pp. 3451-3451
Authors:
HORNBERGER W
RUBSAMEN K
LAUX V
SCHWARZ M
BERNARD H
Citation: W. Hornberger et al., ANTITHROMBIN AND ANTITHROMBOTIC PROPERTIES OF A NEW DECAPEPTIDE THROMBIN EXOSITE INHIBITOR (LU-58463) - COMPARISON WITH HIRUDIN, Thrombosis and haemostasis, 69(6), 1993, pp. 1300-1300
Authors:
RUBSAMEN K
HORNBERGER W
LAUX V
SCHWARZ M
SCHWEDEN J
Citation: K. Rubsamen et al., ANTITHROMBOTIC EFFICACY OF THE POLYETHYLENEGLYCOL-COUPLED HIRUDIN MUTEIN LU-57291 IN EXPERIMENTALLY-INDUCED VENOUS AND ARTERIAL THROMBOSIS, Thrombosis and haemostasis, 69(6), 1993, pp. 1301-1301
Citation: M. Kirchengast et al., INHIBITION BY THE COMBINED CA2-HT2 RECEPTOR ANTAGONIST NEXOPAMIL (LU-49938) OF INTRACORONARY THROMBUS FORMATION IN A CANINE MODEL OF ARTERIAL-STENOSIS AND INTIMAL DAMAGE( AND 5), Journal of cardiovascular pharmacology, 22(5), 1993, pp. 687-694